Drugs / Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes
Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07480161 | Dec 2025 → Dec 2027 expected | erectile dysfunction | Ankara City Hospital Bilkent | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07480161 ↗ |
| Modality | Other / unclassified | “stem cell-derived exosomes have gained increasing attention as a cell-free regenerative therapy.” NCT07480161 ↗ |
| Route | Other | “All treatments will be administered via intracavernosal injection under sterile clinical conditions.” NCT07480161 ↗ |